Intuitive Surgical (NASDAQ:ISRG) Shares Down 0.4% on Insider Selling

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) dropped 0.4% on Tuesday following insider selling activity. The stock traded as low as $563.85 and last traded at $571.10. Approximately 572,352 shares traded hands during trading, a decline of 70% from the average daily volume of 1,933,652 shares. The stock had previously closed at $573.48.

Specifically, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Truist Financial upped their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Performance

The company has a market capitalization of $206.65 billion, a price-to-earnings ratio of 93.28, a P/E/G ratio of 5.19 and a beta of 1.39. The business’s 50-day simple moving average is $549.32 and its 200-day simple moving average is $507.50.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of ISRG. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the third quarter worth approximately $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.